463 related articles for article (PubMed ID: 15693730)
1. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
Harris AH; Gospodarevskaya E; Ritter AJ
Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
[TBL] [Abstract][Full Text] [Related]
2. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N
Drug Alcohol Depend; 2017 May; 174():181-191. PubMed ID: 28371689
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.
Doran CM; Shanahan M; Mattick RP; Ali R; White J; Bell J
Drug Alcohol Depend; 2003 Sep; 71(3):295-302. PubMed ID: 12957347
[TBL] [Abstract][Full Text] [Related]
5. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.
Dijkgraaf MG; van der Zanden BP; de Borgie CA; Blanken P; van Ree JM; van den Brink W
BMJ; 2005 Jun; 330(7503):1297. PubMed ID: 15933353
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
[TBL] [Abstract][Full Text] [Related]
7. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.
Gibson AE; Doran CM; Bell JR; Ryan A; Lintzeris N
Med J Aust; 2003 Jul; 179(1):38-42. PubMed ID: 12831383
[TBL] [Abstract][Full Text] [Related]
8. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Shanahan MD; Doran CM; Digiusto E; Bell J; Lintzeris N; White J; Ali R; Saunders JB; Mattick RP; Gilmour S
Addict Behav; 2006 Mar; 31(3):371-87. PubMed ID: 15972245
[TBL] [Abstract][Full Text] [Related]
12. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial.
Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G
Am J Addict; 2004; 13 Suppl 1():S29-41. PubMed ID: 15204674
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
[TBL] [Abstract][Full Text] [Related]
14. Value for money in drug treatment: economic evaluation of prison methadone.
Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of buprenorphine maintenance versus methadone maintenance.
French MT
Addiction; 2001 Oct; 96(10):1515-7. PubMed ID: 11599513
[No Abstract] [Full Text] [Related]
16. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States.
Barnett PG; Zaric GS; Brandeau ML
Addiction; 2001 Sep; 96(9):1267-78. PubMed ID: 11672491
[TBL] [Abstract][Full Text] [Related]
17. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA
J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
Doran CM; Shanahan M; Bell J; Gibson A
Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
Jackson H; Mandell K; Johnson K; Chatterjee D; Vanness DJ
Subst Abus; 2015; 36(2):226-31. PubMed ID: 25775099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
